Business / Finance

RSS

ProMetic, ProThera form strategic partnership to develop and commercialize Inter-alpha Inhibitor Proteins

ProMetic Life Sciences Inc. announced today that it has entered into a strategic partnership with ProThera Biologics Inc. for the development and commercialization of human plasma-derived Inter-alpha Inhibitor Proteins.

19 Nov 2015

Cell Therapy Catapult initiates construction for cell and gene therapy manufacturing centre

The Cell Therapy Catapult, the UK organisation dedicated to the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, today announces the official initiation of construction for its cell and gene therapy manufacturing centre.

18 Nov 2015

China Pharma's revenue decreases 19.5% to $4.8 million in Q3 2015

China Pharma Holdings, Inc., an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, today announced the financial results for the quarter ended September 30, 2015.

17 Nov 2015

Corning signs agreement to become global distributor for popular BioCision products

Corning Incorporated and BioCision, LLC today announced an agreement that will enable laboratories around the world to further standardize and simplify key steps in their cell culture workflow.

17 Nov 2015

ALPHAEON signs agreement with PhysIOL to develop and commercialize Trifocal lens technology

ALPHAEON Corporation today announced it has entered into a definitive agreement with PhysIOL SA of Belgium, to jointly develop and commercialize an exclusive ALPHAEON-branded Trifocal lens technology. Specific terms of the agreement were not disclosed.

15 Nov 2015

DePuy offers ambulatory surgery outpatient solutions for joint replacement patients

DePuy Synthes Companies announces the national launch of the DEPUY SYNTHES ADVANTAGE™ Outpatient Solutions Program to facilitate best practices and protocols for joint replacement in ambulatory surgical centers (ASCs) and outpatient hospitals throughout the United States.

13 Nov 2015

CASI reports net loss of $1.6 million for third quarter 2015

CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China, today reported financial results for the three and nine months ended September 30, 2015.

13 Nov 2015

Natera's total revenues decrease 2.9% to $44.9 million in third quarter 2015

Natera, Inc., a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today reported financial results for the third quarter ended September 30, 2015 and provided an update on recent business progress.

From Natera 13 Nov 2015

Baylor Miraca Genetics Laboratories licenses SNP probe technology from OGT

Oxford Gene Technology (OGT), The Molecular Genetics Company, has entered into a deal with Baylor Miraca Genetics Laboratories (BMGL), licensing the use of OGT’s proprietary single nucleotide polymorphism (SNP) array probe technology.

From Oxford Gene Technology 12 Nov 2015

Hospice Pharmacy Solutions Completes Merger With Outcome Resources

Hospice Pharmacy Solutions, a Dallas-based pharmacy benefit management service (PBM), announced Monday that it has merged Sacramento-based hospice PBM Outcome Resources into its operations. The announcement was made jointly by Mike Nault, CEO of Hospice Pharmacy Solutions, and Jack Sayler, president of Outcome Resources.

12 Nov 2015

Roka Bioscience reports revenue of $1.5 million for third quarter 2015

Roka Bioscience, Inc., a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, today reported its financial results for the quarter and nine months ended September 30, 2015.

12 Nov 2015

Syneron Medical reports revenue of $62.1 million for third quarter 2015

Syneron Medical Ltd., a leading global aesthetic device company, today announced financial results for the three month period ended September 30, 2015.

11 Nov 2015

LEO Pharma enters into Asset Purchase Agreement to acquire Astellas’ global dermatology business

LEO Pharma A/S, a global healthcare company dedicated to helping people achieve healthy skin, and Japanese pharmaceutical company Astellas Pharma Inc. today announced that they have entered into an Asset Purchase Agreement under which Astellas will transfer its global dermatology business to LEO Pharma for € 675 million.

11 Nov 2015

Juniper Pharmaceuticals’ third quarter product revenues increase 22% to $7.2 million

Juniper Pharmaceuticals, Inc., a women's health therapeutics company, today announced financial results for the three months ended September 30, 2015.

11 Nov 2015

New Global Energy and International Sustainability Group agree to manufacture, distribute MoringaUP Protein Bars

New Global Energy, Inc., a public company focused on Aqua-Farming, Agriculture, and Health & Wellness, has signed a distribution agreement with International Sustainability Group to manufacture and distribute MoringaUP Protein Bars based on ISG's popular AlgaeUp bars.

10 Nov 2015

SKYGEN USA announces launch of Hylis Pharmacy Solutions

Citing a need to bring skyrocketing pharmacy costs under control, SKYGEN USA, the umbrella brand for a distinguished family of benefit management companies and technology solutions for health payers and healthcare organizations, today announced the launch of Hylis Pharmacy Solutions.

10 Nov 2015

Boston Children's and Rock Health team up to accelerate development of pediatric health technologies

Boston Children's Hospital and digital health venture fund Rock Health today announced a strategic partnership aimed at accelerating the development of pediatric health technologies. Detailed today during Boston Children's Hospital's Global Pediatric Innovation Summit + Awards (#PedInno15), the partnership will foster the development of digital tools and devices to improve pediatric care.

10 Nov 2015

Boston Scientific signs definitive agreement to acquire CeloNova's interventional radiology business

Boston Scientific has entered into a definitive agreement to acquire the interventional radiology portfolio of CeloNova Biosciences, a San Antonio-based developer of endovascular and interventional cardiology technologies.

10 Nov 2015

Astellas enters into definitive agreement to acquire Ocata

Astellas Pharma Inc. and Ocata Therapeutics, Inc., a biotechnology company focused on the research and development of new therapies in the field of regenerative medicine, primarily cell therapy addressing unmet medical needs in ophthalmology patients, announced today that they have entered into a definitive agreement.

10 Nov 2015

Nightstar announces $35 million Series B financing round

NightstaRx Ltd, a biopharmaceutical company specialising in developing gene therapies for inherited retinal dystrophies, announces a $35 million Series B financing round. The round was led by New Enterprise Associates, one of the world's leading venture capital firms.

9 Nov 2015

Business / Finance

ProMetic, ProThera form strategic partnership to develop and commercialize Inter-alpha Inhibitor Proteins

Cell Therapy Catapult initiates construction for cell and gene therapy manufacturing centre

China Pharma's revenue decreases 19.5% to $4.8 million in Q3 2015

Corning signs agreement to become global distributor for popular BioCision products

ALPHAEON signs agreement with PhysIOL to develop and commercialize Trifocal lens technology

DePuy offers ambulatory surgery outpatient solutions for joint replacement patients

CASI reports net loss of $1.6 million for third quarter 2015

Natera's total revenues decrease 2.9% to $44.9 million in third quarter 2015

Baylor Miraca Genetics Laboratories licenses SNP probe technology from OGT

Hospice Pharmacy Solutions Completes Merger With Outcome Resources

Roka Bioscience reports revenue of $1.5 million for third quarter 2015

Syneron Medical reports revenue of $62.1 million for third quarter 2015

LEO Pharma enters into Asset Purchase Agreement to acquire Astellas’ global dermatology business

Juniper Pharmaceuticals’ third quarter product revenues increase 22% to $7.2 million

New Global Energy and International Sustainability Group agree to manufacture, distribute MoringaUP Protein Bars

SKYGEN USA announces launch of Hylis Pharmacy Solutions

Boston Children's and Rock Health team up to accelerate development of pediatric health technologies

Boston Scientific signs definitive agreement to acquire CeloNova's interventional radiology business

Astellas enters into definitive agreement to acquire Ocata

Nightstar announces $35 million Series B financing round

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Latest News